Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on therapy for chronic myelogenous leukemia

B B Weinberger1

  • 1LSU Medical Center, Shreveport.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|August 1, 1994
PubMed
Summary

This review covers recent advances in managing chronic myelogenous leukemia (CML), a stem cell disorder. New treatment strategies are emerging from large trials and improved bone marrow transplant options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation.

The Annals of pharmacotherapy·2000
Same author

Central nervous system chloroma.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·1999
Same author

Worldwide Web of bone marrow donors.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·1998
Same author

Acute myelogenous leukemia: review and update on therapy for the primary care physician.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·1995
Same author

Blood stem cell collection with G-CSF.

Bone marrow transplantation·1994
Same author

Applications and indications for bone marrow transplantation in adults.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·1994

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Background:

  • Chronic myelogenous leukemia (CML) is a hematopoietic stem cell disorder.
  • Key features include granulocytic leukocytosis, splenomegaly, and the Philadelphia chromosome.
  • Current treatments include hydroxyurea, busulfan, interferon-alpha, and bone marrow transplantation.

Purpose of the Study:

  • To review recent studies on the management of chronic myelogenous leukemia.
  • To discuss the impact of new therapeutic approaches on CML treatment.

Main Methods:

  • Review of recent large, randomized trials in CML management.
  • Analysis of the increased availability and role of bone marrow transplantation.

Main Results:

  • Emerging data from randomized trials are influencing CML treatment paradigms.
  • Enhanced accessibility of bone marrow transplantation is altering therapeutic strategies.

Conclusions:

  • The therapeutic approach to chronic myelogenous leukemia is evolving.
  • Recent research and transplantation advancements are key drivers of change.

Related Experiment Videos